集束化策略对预防系统性硬皮病患者纤维硬化并发症的效果评价

Evaluation of effects of cluster-based strategies for prevention of the fibrosclerosis complications of patients with systemic scleroderma

目的 探讨集束化护理策略对预防系统性硬皮病患者纤维硬化并发症的应用效果.方法 选择在我科住院治疗的系统性硬皮病患者59例,按随机数字表法分为实验组34例和对照组25例.实验组采取集束化护理策略,包括“一操”“两呼”“三惯”“四防”,以预防患者纤维硬化并发症;对照组采用专科常规护理程序.在患者入院时和出院前分别评估2组患者皮肤硬度、关节功能、雷诺现象、吞咽功能的分值,并比较2组患者的住院天数.结果 干预后实验组皮肤硬度、关节功能、雷诺现象、吞咽功能评分为（14.74±1.33）、（7.06±0.69）、（0.88±0.33）、（0.54±0.21）分,显著优于对照组的（24.08±1.12）、（13.48±0.77）、（1.24±0.60）、（0.96±0.34）分,P＜0.01.实验组与对照组的住院天数分别为（23.65 ±5.45）、（32.00±6.56）d,2组比较差异有统计学意义,t=-5.340,P＜ 0.01.结论 集束化护理策略能有效对抗系统性硬皮病患者的纤维化损害,减少并发症的发生.

objective To explore the effect of application of cluster-based strategies on preventing the complication of fibrosclerosis of patients with systemic scleroderma.Methods A total of 59 patients with systemic scleroderma were randomly assigned to the experimental group （34 cases） and the control group （25 cases） during the period of hospitalization in our department.The experimental group took the cluster-based strategies after admission,including ＆quot;a gymnastics＆quot;,＆quot;two kinds of respiratory breathing＆quot;,＆quot;three kinds of habits＆quot;,＆quot;four kinds of protection＆quot; to prevent the complication of fibrosclerosis.The control group received the conventional care procedures of dermatology.The skin stiffness,joint function,Raynaud39;s phenomenon and swallowing function were evaluated when patients were admitted and before discharge in two groups.The length of stay between the two groups was also compared.Results The skin stiffness,joint function,Raynaud39;s phenomenon and swallowing function scored （14.74±1.33）,（7.06±0.69）,（0.88±0.33）,（0.54±0.21） in the experimental group,significantly better than those of the control group,（24.08±1.12）,（13.48±0.77）,（1.24±0.60）,（0.96±0.34）,P 〈 0.01.The length of stay in the experimental group and the control group was （23.65±5.45）,（32.00±6.56） days,t=-5.340,P 〈 0.01.Conclusions Application of cluster-based strategies can be effective against the fibrosclerosis damage of patients with systemic scleroderma and reduce the occurrence of complications.